Aberdare Ventures II, L.P. - Net Worth and Insider Trading

Aberdare Ventures II, L.P. Net Worth

The estimated net worth of Aberdare Ventures II, L.P. is at least $17 Million dollars as of 2024-03-19. Aberdare Ventures II, L.P. is the 10% Owner of Anacor Pharmaceuticals Inc and owns about 1,751,936 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $17 Million. Details can be seen in Aberdare Ventures II, L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Aberdare Ventures II, L.P. has not made any transactions after 2010-11-30 and currently still holds the listed stock(s).

Transaction Summary of Aberdare Ventures II, L.P.

To

Aberdare Ventures II, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aberdare Ventures II, L.P. owns 2 companies in total, including Reshape Lifesciences Inc () , and Anacor Pharmaceuticals Inc () .

Click here to see the complete history of Aberdare Ventures II, L.P.’s form 4 insider trades.

Insider Ownership Summary of Aberdare Ventures II, L.P.

Ticker Comapny Transaction Date Type of Owner
Reshape Lifesciences Inc 2010-12-14 other: Former 10% stockholder
Anacor Pharmaceuticals Inc 2010-11-30 10 percent owner

Aberdare Ventures II, L.P. Latest Holdings Summary

Aberdare Ventures II, L.P. currently owns a total of 1 stock. Aberdare Ventures II, L.P. owns 1,751,936 shares of Anacor Pharmaceuticals Inc (ANAC) as of November 30, 2010, with a value of $17 Million.

Latest Holdings of Aberdare Ventures II, L.P.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANAC Anacor Pharmaceuticals Inc 2010-11-30 1,751,936 9.82 17,204,012

Holding Weightings of Aberdare Ventures II, L.P.


Aberdare Ventures II, L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, Aberdare Ventures II, L.P. has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the acquisition of 300,000 shares on November 30, 2010, which cost Aberdare Ventures II, L.P. around $2 Million.

Insider Trading History of Aberdare Ventures II, L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aberdare Ventures II, L.P. Trading Performance

GuruFocus tracks the stock performance after each of Aberdare Ventures II, L.P.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aberdare Ventures II, L.P. is 57.8%. GuruFocus also compares Aberdare Ventures II, L.P.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Aberdare Ventures II, L.P. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Aberdare Ventures II, L.P.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Aberdare Ventures II, L.P.

Average Relative Return

0.6%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 4 57.8 30.8 0.6 2.86 40.95
Relative Return to S&P 500(%) -2.55 46.97 18.05 -5.03 -6.65 25.73

Aberdare Ventures II, L.P. Ownership Network

Ownership Network List of Aberdare Ventures II, L.P.

No Data

Ownership Network Relation of Aberdare Ventures II, L.P.


Aberdare Ventures II, L.P. Owned Company Details

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Aberdare Ventures II, L.P. is the other: Former 10% stockholder of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .

Reshape Lifesciences Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Reshape Lifesciences Inc Insider Transactions

No Available Data

Aberdare Ventures II, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for Aberdare Ventures II, L.P.. You might contact Aberdare Ventures II, L.P. via mailing address: One Embarcadero Center Suite 4000 San Francisco Ca 94111.

Discussions on Aberdare Ventures II, L.P.

No discussions yet.